Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies

BACKGROUND: Oral pharmacotherapies to treat overactive bladder (OAB) are used less in men despite a similar prevalence of storage symptoms as women. The efficacy and safety of once-daily mirabegron 50 mg was evaluated in male OAB patients from five phase III studies that included placebo or antimusc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Urol
Main Authors: Tubaro, Andrea, Batista, José E., Nitti, Victor W., Herschorn, Sender, Chapple, Christopher R., Blauwet, Mary Beth, Siddiqui, Emad, Huang, Moses, Oelke, Matthias
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444577/
https://ncbi.nlm.nih.gov/pubmed/28588652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287217702797
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados